← SynDRA
ERAVACYCLINE
SynDRA canonical compound SYN0028739 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Mechanism of action | antibacterial | bacterial 30s ribosomal subunit inhibitor |
| Indication | gram-positive bacterial infections |
| Disease area | infectious disease |
Mechanisms of action (all sources)
- bacterial 30s ribosomal subunit inhibitor
Drug classes
ATC classes
Cross-references
Synonyms
- XERAVA
- Xerava
- eravacycline dihydrochloride
- xerava
- TP-434
- Eravaciclina
- Tp-434
- TP-038
- TP-120
- TP-170
- TP-221
- TP-271
- TP-787
- Tetracycline analogs (bacterial infection), Tetraphase Pharmaceuticals
- Tetracycline derivatives (bacterial infection), Tetraphase Pharmaceuticals
- Fluorocycline antibiotic (oral, bacterial infection), Tetraphase Pharmaceuticals
- Tetracycline analogs (iv, antibiotic), Tetraphase Pharmaceuticals
- TP-434 (oral, multidrug-resistant bacterial infections)
- TP-434 (oral, multidrug-resistant bacterial infections), Tetraphase Pharmaceuticals
- UNII-Y6IUM7395Q
- Y6IUM7395Q
- CHEMBL2057236
- SCHEMBL13397803
- GTPL11013
- TP271
- DB15040
- Eravacycline dihydrochloride
- RefChem:933224
- Eravacycline [USAN]
- Eravacycline [USAN:INN]
- eravaciclina
- TP434
- UNII-07896928ZC
- YQM
- TP434;Eravacycline
- ERAVACYCLINE [MI]
- Eravacycline (USAN/INN)
- ERAVACYCLINE [INN]
Reported adverse events
- Hypersensitivity
- Nausea
- Vomiting
- Infusion site reaction
- Hypotension
- Wound dehiscence
- Wound
Look up ERAVACYCLINE in the interactive SynDRA portal →